Tekla Capital Management LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$6,049,000
+108.9%
289,029
+39.3%
0.23%
+75.6%
Q1 2020$2,895,000
-38.7%
207,5550.0%0.13%
-26.8%
Q4 2019$4,724,000
+95.4%
207,5550.0%0.18%
+70.5%
Q3 2019$2,418,000207,5550.10%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders